Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10259/9526
Título
Enhancement of the Proapoptotic Properties of Newcastle Disease Virus Promotes Tumor Remission in Syngeneic Murine Cancer Models
Autor
Publicado en
Molecular Cancer Therapeutics. 2015, V. 14, n. 5, p. 1247–1258
Editorial
American Association for Cancer Research
Fecha de publicación
2015-05
ISSN
1535-7163
DOI
10.1158/1535-7163.MCT-14-0913
Abstract
Newcastle disease virus (NDV) is considered a promising agent for cancer therapy due to its oncolytic properties. These include preferential replication in transformed cells, induction of innate and adaptive immune responses within tumors, and cytopathic effects in infected tumor cells due to the activation of apoptosis. To enhance the latter and thus possibly enhance the overall oncolytic activity of NDV, we generated a recombinant NDV encoding the human TNF receptor Fas (rNDV-B1/Fas). rNDV-B1/Fas replicates to similar titers as its wild-type (rNDV-B1) counterpart; however, overexpression of Fas in infected cells leads to higher levels of cytotoxicity correlated with faster and increased apoptosis responses, in which both the intrinsic and extrinsic pathways are activated earlier. Furthermore, in vivo studies in syngeneic murine melanoma models show an enhancement of the oncolytic properties of rNDV-B1/Fas, with major improvements in survival and tumor remission. Altogether, our data suggest that upregulation of the proapoptotic function of NDV is a viable approach to enhance its antitumor properties and adds to the currently known, rationally based strategies to design optimized therapeutic viral vectors for the treatment of cancer.
Palabras clave
Fas
Apoptosis
Oncolytic
Virotherapy
Recombinant virus
Materia
Medicina
Medicine
Salud
Health
Microbiología
Microbiology
Versión del editor
Collections